secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2026-01-20T23:59:59+00:00
Accession:  0001437749-26-001484
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech posts corporate presentation on website; no material new details disclosed
--------------------------------------------------------------------------------

- Company furnished investor presentation dated January 2026 as Exhibit 99.1.
- Presentation posted on company website under Item 7.01 Regulation FD disclosure.
- No specific financial or clinical updates provided in the filing text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926001484/0001437749-26-001484-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926001484/mbrx20260113_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-001484

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer